SEC 13F Intelligence

Endurant Capital Management LP / BSX

Endurant Capital Management LP’s Boston Scientific Corp Position

Does Endurant Capital Management LP own Boston Scientific Corp (BSX)? Not currently — the last reported position was 39.1K shares worth $2M in Q4 2023; the fund’s latest 13F (Q1 2024) no longer reports it.

Position Value
$2M
Q4 2023
Shares
39.1K
% of Portfolio
+12.96%
Quarters Held
7
position exited

Position History BSX

Reported value by quarter
Q4 ’18: $1MQ4 ’18Q2 ’20: $4MQ2 ’20Q1 ’21: $6MQ1 ’21Q2 ’22: $16MQ2 ’22Q2 ’23: $3MQ2 ’23Q3 ’23: $3MQ3 ’23Q4 ’23: $2MQ4 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q4 202339.1K$2M+12.96%
Q3 202347.9K$3M+2.27%
Q2 202361.0K$3M+2.88%
Q2 2022418.2K$16M+5.47%
Q1 2021158.7K$6M+1.60%
Q2 2020106.3K$4M+0.20%
Q4 201830.6K$1M+0.57%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Endurant Capital Management LP’s full portfolio or all institutional holders of BSX.